Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Krebs Biochemicals & Industries Ltd

Pharmaceuticals & Biotechnology | Small Cap

Krebs Biochemicals & Industries Ltd Health Insights
Health Score : 4.16Health Score : 4.16

Krebs Biochemicals & Industries Ltd, operating in the Healthcare Services sector, shows a mixed financial performance. The company exhibits strengths in solvency, efficiency, and growth, but struggles with liquidity, coverage, financial metrics, and profitability. While the company showcases good performance in managing its debts and generating profits from its operations, it faces challenges in meeting its short-term obligations and ensuring consistent revenue growth. The negative profitability margins and low coverage ratios raise concerns about the company's financial sustainability. Overall, the company needs to address its liquidity and profitability issues to improve its financial health and stability.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Krebs Biochemicals & Industries Ltd Health Insights
Health Score : 4.16Health Score : 4.16

Krebs Biochemicals & Industries Ltd, operating in the Healthcare Services sector, shows a mixed financial performance. The company exhibits strengths in solvency, efficiency, and growth, but struggles with liquidity, coverage, financial metrics, and profitability. While the company showcases good performance in managing its debts and generating profits from its operations, it faces challenges in meeting its short-term obligations and ensuring consistent revenue growth. The negative profitability margins and low coverage ratios raise concerns about the company's financial sustainability. Overall, the company needs to address its liquidity and profitability issues to improve its financial health and stability.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Highly Undervalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Highly Undervalued

P/E RATIO (TTM)

-5.17

Highly Undervalued

Industry Median

28.62

Highly Undervalued
Highly Undervalued

Small Cap Median

27.17

Highly Undervalued

P/E RATIO

-5.27

P/B RATIO

-0.90

Highly Undervalued

Industry Median

3.17

Highly Undervalued
Highly Undervalued

Small Cap Median

2.62

Highly Undervalued

P/S RATIO

3.31

Neutral

Industry Median

3.42

Neutral
Overvalued

Small Cap Median

2.55

Overvalued

Others

Highly Undervalued

PEG RATIO

-4.29

Highly Undervalued
Highly Undervalued

EV/EBITDA RATIO

-21.80

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹65.89 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 7.20

The company exhibits strong growth in operating profit, EPS, and net income, but revenue and assets have declined. This suggests improved profitability despite revenue challenges. The company's ability to grow profits faster than revenue indicates enhanced operational efficiency. However, declining revenue and assets raise concerns about sustainability. Focus on revenue generation and asset growth is essential for long-term success.

PoorRevenue Growth RatePoor
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
PoorAsset Growth RatePoor
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue Growth Rate63.6411.11-13.33-3.85-14
Operating Profit Growth Rate-5.2688.89-52.94-43.7566.67
Earnings Per Share (EPS) Growth-9.9142.91-44.55-20.0936.61
Asset Growth Rate19.5-7.891.71-5.06
Net Income Growth Rate-3.4560.71-44.44-2035
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.40

The company's financial ratios reflect a concerning financial position. Negative adjusted EPS, cash EPS, and book value per share indicate poor profitability and asset value. The lack of dividend payments and moderate capital expenditures further highlight financial challenges. Addressing these issues is crucial for restoring financial stability and investor confidence.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
PoorCash Earnings Per Share (Cash EPS)Poor
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
WeakCapital Expenditures (CapEx)Weak
Financial RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Adjusted Earnings Per Share (Adjusted EPS)-14-20.45-11.36-9.09-12.33
Cash Earnings Per Share (Cash EPS)-11.5-17.73-8.18-5.91-9.09
Book Value Per Share-21-34.09-45-54.09-66.36
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)17.827.115.27.33.4
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 2.00

The company's profitability ratios are significantly negative, indicating poor financial performance. Negative gross profit margin, ROCE, ROE, ROA, operating margin, and net margin raise severe concerns about its ability to generate profits. Addressing these issues is essential for ensuring its long-term sustainability.

PoorGross Profit MarginPoor
PoorReturn on Capital Employed (ROCE)Poor
PoorReturn on Equity (ROE)Poor
PoorReturn on Assets (ROA)Poor
PoorOperating MarginPoor
PoorNet MarginPoor
Profitability RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Gross Profit Margin-42.59-66.67-44.23-32-51.16
Return on Capital Employed (ROCE)-40-57-29-19-30
Return on Equity (ROE)
Return on Assets (ROA)-11.32-17.89-9.14-5.06-8.88
Operating Margin-33.33-56.67-30.77-18-34.88
Net Margin-51.85-75-48.08-40-62.79
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 6.00

The company demonstrates mixed efficiency ratios. While it excels in receivables management, its fixed asset and capital turnover are low, and inventory management is average. High receivables turnover and quick collection periods indicate effective credit policies. However, inefficient use of fixed assets and capital, along with moderate inventory turnover, suggest operational inefficiencies. Improvement in asset utilization and inventory control could enhance overall efficiency and profitability.

PoorFixed Asset Turnover RatioPoor
AverageInventory Turnover RatioAverage
ExcellentReceivables Turnover RatioExcellent
AverageDays Sales in Inventory RatioAverage
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Fixed Asset Turnover Ratio0.460.430.350.330.29
Inventory Turnover Ratio4.584.7446.078.21
Receivables Turnover Ratio182.57391.2526.07
Days Sales in Inventory Ratio79.697791.2560.1344.46
Receivable Days254140
Capital Turnover Ratio1.8-0.83-0.93-0.77-0.37
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 2.00

The company's coverage ratios are very low, indicating a weak ability to meet its interest and dividend obligations. Negative interest coverage ratio and lack of equity dividend coverage raise concerns about financial risk. Low coverage ratios could limit the company's ability to leverage debt and sustain dividend payments. Addressing this issue is vital for maintaining financial stability.

PoorInterest Coverage RatioPoor
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Interest Coverage Ratio-3.67-8-7.33-3-3.5
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 4.40

The company's solvency ratios present a mixed picture. While the Debt to Equity ratio is strong, The high debt ratio and very high debt to asset ratio suggest reliance on debt financing, while the negative equity ratio indicates financial distress. Overall, while there are some strengths, the company's solvency is concerning due to high debt levels and negative equity, which could pose risks to its long-term financial stability.

PoorDebt RatioPoor
ExcellentDebt to Equity RatioExcellent
PoorEquity RatioPoor
PoorDebt To Asset RatioPoor
Solvency RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debt Ratio1.72.292.342.8310.73
Debt to Equity Ratio-2.43-1.78-1.75-1.55-1.1
Equity Ratio-0.7-1.29-1.34-1.83-9.73
Debt To Asset Ratio0.640.70.991.030.95
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is weak, indicating potential difficulties in meeting short-term obligations. Low current, quick, and cash ratios suggest limited liquid assets to cover immediate liabilities. Negative operating cash flow ratios further exacerbate these concerns, reflecting poor cash generation from core operations. This situation could impact the company's ability to invest in growth opportunities or handle unexpected financial challenges. While the industry might face seasonal fluctuations, the consistently low ratios point to more structural issues that need attention.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Current Ratio0.290.330.240.230.13
Quick Ratio0.120.130.120.140.09
Cash Ratio0.010000
Operating Cash Flow Ratio-0.15-0.13-0.250.02-0.05
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 7 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Par Drugs & Chemicals Ltd7.408.91Undervalued17.0010.6513.00
2Vaishali Pharma Ltd6.74103.62Overvalued4.000.314.00
3Quest Laboratories Ltd5.2711.21Neutral18.009.1615.00
4Sotac Pharmaceuticals Ltd5.2721.26Neutral18.004.456.00
5Zenith Drugs Ltd4.637.52Neutral17.002.3010.00
6Krebs Biochemicals & Industries Ltd4.16-5.27Highly Undervalued-4.00-12.49-4.00
Management Assessment Summary
RedWeak Management

The management effectiveness of Krebs Biochemicals & Industries Ltd appears weak. The company exhibits negative profit margins, inconsistent sales growth, and negative returns on capital employed. While promoter holding is high, the negative financial performance raises concerns about management's ability to steer the company towards profitability and sustainable growth. The company's reliance on debt financing, coupled with its inability to generate profits, further exacerbates the situation. Absence of dividend payouts reflects the poor financial health.

Category Metric Value Assessment
PROS Promoter Holding 72.74% High promoter holding indicates alignment with shareholders.
CONS Sales Growth (TTM) -14% Declining sales growth.
Operating Profit Margin (Mar 2025) -88.69% Poor operational efficiency.
Return on Capital Employed (ROCE) -30% Inefficient use of capital.
PoorFinancial Performance & GrowthPoor
PoorCapital Efficiency & ReturnsPoor
WeakFinancial Health & PrudenceWeak
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
RedWeak Risk

Krebs Biochemicals & Industries Ltd exhibits high financial risk due to negative profit margins, inconsistent sales, and negative ROCE which highlight operational inefficiencies. Increasing borrowings and negative net worth raise concerns about long-term viability. These factors contribute to a high-risk profile.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
AverageSegment performance volatilityAverage
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1065.31Bullish
  3. SMA 2065.51Bullish
  4. SMA 5065.43Bullish
  5. EMA 1065.49Bullish
  6. EMA 2065.52Bullish
  7. EMA 5065.56Bullish
  8. DEMA 1065.50Bullish
  9. DEMA 2065.44Bullish
  10. DEMA 5065.73Bullish
  11. TEMA 1065.60Bullish
  12. TEMA 2065.42Bullish
  13. TEMA 5065.27Bullish
  14. MACD-0.06Bullish
  15. ADX14.37Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.39Neutral
  3. CCI10.61Neutral
  4. ROC 9-0.17Bearish
  5. ROC 141.38Bullish
  6. ROC 254.16Bullish
  7. Stoch K47.27Neutral
  8. Stoch D47.68Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper66.67Neutral
  3. BB Middle65.50Neutral
  4. BB Lower64.34Neutral
  5. ATR0.93Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI49.43Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1065.32Bullish
  3. SMA 2065.61Bullish
  4. SMA 5065.76Bullish
  5. EMA 1065.46Bullish
  6. EMA 2065.51Bullish
  7. EMA 5065.21Bullish
  8. DEMA 1065.42Bullish
  9. DEMA 2065.43Bullish
  10. DEMA 5066.29Bearish
  11. TEMA 1065.47Bullish
  12. TEMA 2065.31Bullish
  13. TEMA 5065.71Bullish
  14. MACD-0.06Bearish
  15. ADX26.49Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI51.82Neutral
  3. CCI-5.05Neutral
  4. ROC 91.37Bullish
  5. ROC 141.53Bullish
  6. ROC 255.92Bullish
  7. Stoch K44.70Neutral
  8. Stoch D44.25Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper67.22Neutral
  3. BB Middle65.61Neutral
  4. BB Lower64.00Neutral
  5. ATR1.58Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI66.19Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1065.55Bullish
  3. SMA 2065.83Bullish
  4. SMA 5063.32Bullish
  5. EMA 1065.53Bullish
  6. EMA 2065.39Bullish
  7. EMA 5063.77Bullish
  8. DEMA 1065.52Bullish
  9. DEMA 2066.01Bearish
  10. DEMA 5066.67Bearish
  11. TEMA 1065.46Bullish
  12. TEMA 2065.44Bullish
  13. TEMA 50N/AN/A
  14. MACD0.38Bearish
  15. ADX33.61Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.59Neutral
  3. CCI-28.97Neutral
  4. ROC 9-1.49Bearish
  5. ROC 140.05Bullish
  6. ROC 252.94Bullish
  7. Stoch K47.17Neutral
  8. Stoch D45.46Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper68.14Neutral
  3. BB Middle65.83Neutral
  4. BB Lower63.53Neutral
  5. ATR2.51Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI71.08Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1065.62Bearish
  3. SMA 2064.48Bearish
  4. SMA 5061.53Bullish
  5. SMA 10058.18Bullish
  6. SMA 20064.03Bullish
  7. EMA 1065.13Bearish
  8. EMA 2064.13Bullish
  9. EMA 5061.60Bullish
  10. EMA 10061.22Bullish
  11. EMA 20064.47Bearish
  12. DEMA 1065.71Bearish
  13. DEMA 2066.25Bearish
  14. DEMA 5063.98Bullish
  15. DEMA 10059.34Bullish
  16. DEMA 20057.41Bullish
  17. TEMA 1065.09Bearish
  18. TEMA 2066.29Bearish
  19. TEMA 5066.72Bearish
  20. TEMA 10062.49Bullish
  21. TEMA 20056.41Bullish
  22. MACD1.50Bearish
  23. ADX24.58Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI52.61Neutral
  3. CCI19.26Neutral
  4. ROC 14-1.30Bearish
  5. ROC 259.84Bullish
  6. Stoch K44.97Neutral
  7. Stoch D49.49Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper69.98Neutral
  3. BB Middle64.48Neutral
  4. BB Lower58.97Neutral
  5. ATR3.96Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI73.94Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2057.50Bullish
  3. SMA 5066.37Bearish
  4. EMA 2060.67Bullish
  5. EMA 5065.52Bearish
  6. DEMA 2058.94Bullish
  7. DEMA 5057.73Bullish
  8. TEMA 2061.81Bullish
  9. TEMA 5055.56Bullish
  10. MACD-0.72Bullish
  11. ADX17.40Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI51.06Neutral
  3. CCI-3.67Neutral
  4. ROC 1420.77Bullish
  5. ROC 25-6.05Bearish
  6. Stoch K81.21Overbought
  7. Stoch D75.80Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper68.85Neutral
  3. BB Middle57.50Neutral
  4. BB Lower46.14Neutral
  5. ATR7.46High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI84.77Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 658.25Bullish
  3. SMA 1266.17Bearish
  4. SMA 2474.83Bearish
  5. EMA 660.13Bullish
  6. EMA 1264.34Bullish
  7. EMA 2470.84Bearish
  8. DEMA 657.22Bullish
  9. DEMA 1257.05Bullish
  10. DEMA 2459.96Bullish
  11. TEMA 659.23Bullish
  12. TEMA 1255.20Bullish
  13. TEMA 2458.11Bullish
  14. MACD-11.81Bearish
  15. ADX26.54Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI46.88Neutral
  3. CCI-76.32Neutral
  4. ROC 25-8.68Bearish
  5. ROC 50-54.45Bearish
  6. Stoch K17.22Oversold
  7. Stoch D28.74Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper102.84Neutral
  3. BB Middle73.36Neutral
  4. BB Lower43.87Neutral
  5. ATR19.08Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI74.52Neutral